Complement Activation in Patients with Focal Segmental Glomerulosclerosis. - Wikidata - awgldk - TriplyDB

Complement Activation in Patients with Focal Segmental Glomerulosclerosis.

Complement Activation in Patients with Focal Segmental Glomerulosclerosis.

http://www.wikidata.org/entity/Q35763276

about

Immunologic Changes Implicated in the Pathogenesis of Focal Segmental Glomerulosclerosis Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.Focal segmental glomerulosclerosis lagged behind the onset of rheumatoid arthritis by 7 years: A case report and literature review.IgM as a novel predictor of disease progression in secondary focal segmental glomerulosclerosis IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?Complement in Non-Antibody-Mediated Kidney Diseases.Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Investigational drugs in development for focal segmental glomerulosclerosis.Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease

P2860

Q26753833-B61537F8-0A17-40B0-8447-FDBEB46BF98B Q33826145-30EEEF4F-B2E5-4444-986B-6DD8BF87C0D1 Q37582660-D93AA749-5E15-45F1-869F-48DE85459C28 Q38600476-721DBAE4-37A5-407E-BD02-67B5C3E5961E Q38722114-914C2257-8133-44DD-9AFC-A99A53AC47D0 Q40986583-80D067AC-03E9-4555-8456-04890004A86F Q41022459-5C7C0D8E-99E2-495D-B806-4B1033FDF88E Q42086661-0F1AD861-BA20-469C-A6DC-4788E599C328 Q51840896-A94E3F00-FFDF-45CE-B5F9-4B79D6CF41E6 Q56341973-50920948-65C8-4693-A0C3-80D856717D20

P2860

Complement Activation in Patients with Focal Segmental Glomerulosclerosis.

http://www.wikidata.org/entity/Q35763276

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Complement Activation in Patients with Focal Segmental Glomerulosclerosis.

@ast

Complement Activation in Patients with Focal Segmental Glomerulosclerosis.

@en

type

label

Complement Activation in Patients with Focal Segmental Glomerulosclerosis.

@ast

Complement Activation in Patients with Focal Segmental Glomerulosclerosis.

@en

prefLabel

Complement Activation in Patients with Focal Segmental Glomerulosclerosis.

@ast

Complement Activation in Patients with Focal Segmental Glomerulosclerosis.

@en

P1433

Q35763276-E5FD8DED-E21A-4845-9050-0C7925DCBD0D

P1476

Q35763276-6E00AE23-A303-4591-BB7B-98951632B251

P2093

Q35763276-17D83D7E-9A35-46D7-975A-6B7BFF19641A

Q35763276-2C731AA1-D892-482A-A531-3F23DFCC575C

Q35763276-5BA0CF1F-8E5D-4098-ADD1-369F76EEDA21

Q35763276-644C8F93-F6A8-4144-B52C-CCCBD24FA787

Q35763276-A06CBAE7-E44A-45BF-A27C-F1B204116DB2

Q35763276-BF66549E-CFB3-4328-AB79-ABC83B10DFB9

Q35763276-C8B810B1-ED65-4340-A1E0-0D45BA611521

Q35763276-CA574488-96DF-4C81-8C52-FD5369989A10

Q35763276-D92F023B-1C0B-46A9-ADB7-C64F43487048

Q35763276-EAD4B162-C3D9-48BB-B4F9-614E90943C12

P2860

Q35763276-0D871659-A0F1-4764-BC85-F98EFDF815D0

Q35763276-10334FFF-3D9C-4761-925F-8E357897C8A5

Q35763276-1112F900-C2B9-42F7-8D24-01FAC7AF3BE8

Q35763276-13B3DFFB-07B4-46CF-BD62-753C7764F34D

Q35763276-14E7C827-F1D2-4641-94A7-247D786115E4

Q35763276-193645F4-8E9F-42F2-8EDB-D51AF62DE129

Q35763276-22357E1C-D879-40E5-B58D-C5BD0F0C4776

Q35763276-34609888-1F80-47D4-921A-B196F33EE56E

Q35763276-45B3A9DD-E8E9-458E-8030-622D27128725

Q35763276-6D4D6B20-E909-4491-9CBD-FE2C1263A495

P304

Q35763276-D07083B7-F9F6-4530-9CF6-DEB10D6179F3

P31

Q35763276-DDE10805-4155-47B0-B6F5-726C0B72D634

P356

Q35763276-CEE9FE07-EF1B-400B-9849-02A5E629439C

P407

Q35763276-C6EDD6E3-47FC-43BE-97A8-B624344A20D1

P433

Q35763276-731C1570-88EE-4E6D-A550-381EB1B67D25

P478

Q35763276-71D696C4-FB63-4820-84CF-18BD611C1189

P50

Q35763276-0D2158F0-0F3D-453D-9D21-225ED70CE0B5

Q35763276-5864E135-8512-4CC1-A3EB-AFE8EE9FE9DA

Q35763276-9FDF5FD7-E870-4D2B-BC66-1EEC9F37F99C

Q35763276-B836045B-4915-4DBF-AD78-1598343AC78A

P577

Q35763276-25FB56E7-FAD8-4FBA-AD7F-190D59AD7B58

P5875

Q35763276-CC252E48-30DF-44B2-90B5-CD3A956487CF

P698

Q35763276-8C512662-C339-413F-9B75-E044973E1679

P932

Q35763276-4409CEEE-3293-4CA3-98E8-EE00BBB4A126

P356

JOURNAL.PONE.0136558

P1433

P1476

Complement Activation in Patients with Focal Segmental Glomerulosclerosis.

@en

P2093

Aaron Friedman

http://www.w3.org/2001/XMLSchema#string

Ashley Frazer-Abel

http://www.w3.org/2001/XMLSchema#string

Brandon Renner

http://www.w3.org/2001/XMLSchema#string

Frederick Kaskel

http://www.w3.org/2001/XMLSchema#string

Jennifer Gassman

http://www.w3.org/2001/XMLSchema#string

Joshua M Thurman

http://www.w3.org/2001/XMLSchema#string

Maria Wong

http://www.w3.org/2001/XMLSchema#string

Melanie S Joy

http://www.w3.org/2001/XMLSchema#string

Milena K Radeva

http://www.w3.org/2001/XMLSchema#string

Patricia C Giclas

http://www.w3.org/2001/XMLSchema#string

P2860

Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome.

Treatment of primary FSGS in adults

Complement. First of two parts

Eculizumab in a patient with dense-deposit disease

Systemic complement activation in age-related macular degeneration

C3 requirements for formation of alternative pathway C5 convertase

Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life

Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy.

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.

The prevalence of immunologic injury in renal allograft recipients with de novo proteinuria.

P304

e0136558

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0136558

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Howard Trachtman

Debbie S Gipson

Jennifer Gassman

P577

2015-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281515526

http://www.w3.org/2001/XMLSchema#string

P698

26335102

http://www.w3.org/2001/XMLSchema#string

P932

4559462

http://www.w3.org/2001/XMLSchema#string